Alnylam Pharmaceuticals
ALNY
#992
Rank
$18.77 B
Marketcap
$148.43
Share price
-1.07%
Change (1 day)
-21.33%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Number of shares outstanding for Alnylam Pharmaceuticals (ALNY)

Number of shares outstanding as of June 2024 : 126,138,000

According to Alnylam Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 126,138,000. At the end of 2024 the company had 126,138,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Alnylam Pharmaceuticals from 2003 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.12 B0.42%
20230.12 B1.9%
20220.12 B2.92%
20210.11 B3.01%
20200.11 B4.05%
20190.11 B10.57%
20180.10 B5.12%
201796.13 M11.99%
201685.84 M1.15%
201584.87 M10.28%
201476.95 M22.33%
201362.9 M21.4%
201251.82 M21.49%
201142.65 M1.26%
201042.12 M1%
200941.7 M1.24%
200841.19 M5.57%
200739.02 M21.49%
200632.12 M53.59%
200520.91 M7.21%
200419.5 M2209.85%
20030.84 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
2,044,000,000 1,520.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
2,497,600,000 1,880.05%๐Ÿ‡ซ๐Ÿ‡ท France
107,800,000-14.54%๐Ÿ‡บ๐Ÿ‡ธ USA
93,991,000-25.49%๐Ÿ‡บ๐Ÿ‡ธ USA
28,746,802-77.21%๐Ÿ‡บ๐Ÿ‡ธ USA
706,882,189 460.40%๐Ÿ‡บ๐Ÿ‡ธ USA
1,123,000,000 790.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
123,285,000-2.26%๐Ÿ‡บ๐Ÿ‡ธ USA